A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) at a Dose of 30 mcg/kg-IBW/hr (iNO 30) in Subjects at Risk of Pulmonary Hypertension Associated with Pulmonary Fibrosis (PH-PF) on Long Term Oxygen Therapy